Functional proteomics of colon cancer Consensus Molecular Subtypes-Reference-Cited by-同舟云学术

Functional proteomics of colon cancer Consensus Molecular Subtypes

Published:2024-03-14 Issue:10 Volume:130 Page:1670-1678
ISSN:0007-0920
Container-title:British Journal of Cancer
language:en
Short-container-title:Br J Cancer

Author:

Feliu Jaime,Gámez-Pozo Angelo,Martínez-Pérez Daniel,Pérez-Wert Pablo,Matamala-Luengo Daniel,Viñal David,Kunz Laura,López- Vacas Rocío,Dittmann Antje,Rodríguez-Salas Nuria,Custodio Ana,Fresno Vara Juan Ángel,Trilla-Fuertes Lucía^ORCID

Publisher

Springer Science and Business Media LLC

Link

https://www.nature.com/articles/s41416-024-02650-6.pdf

Reference55 articles.

1. Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71:209–49.

2. Argilés G, Tabernero J, Labianca R, Hochhauser D, Salazar R, Iveson T, et al. Localised colon cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2020;31:1291–305.

3. Viñal D, Martinez-Recio S, Martinez-Perez D, Ruiz-Gutierrez I, Jimenez-Bou D, Peña-Lopez J, et al. Clinical score to predict recurrence in patients with stage II and stage III colon cancer. Cancers (Basel). 2022;14:5891.

4. Weiser MR, Hsu M, Bauer PS, Chapman WC, González IA, Chatterjee D, et al. Clinical calculator based on molecular and clinicopathologic characteristics predicts recurrence following resection of stage I-III colon cancer. J Clin Oncol. 2021;39:911–9.

5. Marshall JL, Haller DG, de Gramont A, Hochster HS, Lenz HJ, Ajani JA, et al. Adjuvant therapy for stage II and III colon cancer: Consensus Report of the International Society of Gastrointestinal Oncology. Gastrointest Cancer Res. 2007;1:146–54.